---

$1.58

+0.0250 ( +0.32% ) 189.1K

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-12	Sale	-182453.00	HUNT RONALD
2024-08-12	Sale	-82613.00	Fishman Corey N.
2024-08-12	Sale	-106247.00	Dunne Michael W.
2023-12-27	Buy	25000.00	Dunne Michael W.
2023-12-19	Buy	10000.00	Dunne Michael W.
2023-12-04	Sale	-8333.00	Puttagunta Sailaja
2023-11-27	Buy	20000.00	Dunne Michael W.
2023-11-20	Buy	10000.00	Fishman Corey N.
2023-10-02	Sale	-5479.00	HUNT RONALD
2023-10-02	Sale	-3487.00	Dunne Michael W.

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.